We are live on
!
Find out more
EPRS
EPIRUS BIOPHARMACEUTICALS INC COM
EPRS
EPRS
Delisted
EPRS was delisted on the 3rd of August, 2016.
32 hedge funds and large institutions have $2.6M invested in EPIRUS BIOPHARMACEUTICALS INC COM in 2016 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 4 increasing their positions, 8 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
14% less funds holding
Funds holding: 37 → 32 (-5)
36% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 14
50% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 8
93% less capital invested
Capital invested by funds: $34.8M → $2.6M (-$32.2M)
Holders
32
Holders Change
-5
Holders Change %
-13.51%
% of All Funds
0.85%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
4
Reduced
8
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
VKH
Virtu KCG Holdings
New York
|
+$190K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$63.5K |
| 3 |
Goldman Sachs
New York
|
+$26.9K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$14.1K |
| 5 |
Walleye Trading
New York
|
+$2.57K |
Top Sellers
| 1 |
Jennison Associates
New York
|
-$7.03M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.7M |
| 3 |
BC
Broadfin Capital
New York
|
-$2.9M |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$2.41M |
| 5 |
B
Bailard
Foster City,
California
|
-$1.63M |
